8/8/08 update
It was a good week for the Nasdaq Composite Index, which closed Friday down -8.98% YTD (vs. -12.87% YTD a week ago). However, the Nasdaq Biotech Index actually fell back a bit, closing Friday up 8.73% YTD (vs. up 9.11% YTD a week ago). And, unfortunately, the Contest portfolios had a much tougher week, the median closing down -6.85% YTD (vs. down -3.15% YTD a week ago).
At week's end, 14 of the 33 Contest portfolios were in the black YTD with still just 6 of the portfolios beating the NBI. Unsurprisingly, GENE's portfolio continued to lead the pack, closing the week with a 98.2% YTD gain. ROBERT's portfolio held on to second place with a 45.0% YTD gain.
Enjoy the weekend biofreaks!
Below is the Top Ten list on 8/8/08:
8/8/08
Rank Name Total
1 GENE 98,233
2 ROBERT 44,998
3 JACK 28,074
4 CASA 14,091
5 HAMMER 11,301
6 LJM 10,505
7 ASHLEY 6,137
8 ROCKY9 6,100
9 BULBA 5,378
10 RCMAC 4,725
Portfolio adjustments: I reallocated the IOMI buyout funds in GENE's portfolio using 8/8 closing prices.
(All corrections, especially adjustments for splits, greatly appreciated.) |
